tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

IMEXHS Limited Reports Increased Losses Amidst Revenue Decline

Story Highlights
IMEXHS Limited Reports Increased Losses Amidst Revenue Decline

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from ImExHS Limited ( (AU:IME) ) is now available.

IMEXHS Limited reported a slight decrease in revenues by 0.9% to $13.66 million for the half-year ending June 2025, alongside a significant increase in losses by 97.9% to $3 million. No dividends were declared during this period, and the financial statements received an unmodified opinion with an emphasis on going concern, highlighting challenges in the company’s financial performance.

The most recent analyst rating on (AU:IME) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.

More about ImExHS Limited

IMEXHS Limited operates in the medical imaging technology industry, providing advanced imaging solutions and services. The company focuses on delivering innovative products to healthcare providers, enhancing diagnostic capabilities and patient care.

Average Trading Volume: 32,732

Technical Sentiment Signal: Sell

Current Market Cap: A$12.07M

Learn more about IME stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1